Thalys Medical Technology Group Inc
SSE:603716
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Thalys Medical Technology Group Inc
SSE:603716
|
CN |
|
Aldebaran Resources Inc
XTSX:ALDE
|
CA |
|
Chengdu Xingrong Environment Co Ltd
SZSE:000598
|
CN |
|
Livetech da Bahia Industria e Comercio SA
BOVESPA:LVTC3
|
BR |
Multiples-Based Value
The Multiples-Based Value of one
Thalys Medical Technology Group Inc
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 22.72 CNY,
Thalys Medical Technology Group Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Thalys Medical Technology Group Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Thalys Medical Technology Group Inc
SSE:603716
|
4.8B CNY | 3.8 | -19.9 | -44.7 | -44.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
375.5B USD | 6.1 | 89.7 | 14.8 | 20.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.7B USD | 5.2 | 24.8 | 14.4 | 14.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
176.3B USD | 6 | 20.7 | 12.9 | 16 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.5B USD | 9.5 | 28.7 | 21.6 | 22.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.2B USD | 5.7 | 18 | 13.5 | 15.4 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.9B EUR | 11.8 | 37.9 | 40.9 | 41.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 32.7 | 11 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |